Annual report [Section 13 and 15(d), not S-K Item 405]

Share-Based Compensation

v3.25.0.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2024
Share-Based Compensation.  
Share-Based Compensation

14.  SHARE-BASED COMPENSATION

Effective July 1, 2015, our eligible employees commenced participation in the 2015 LTIP.  The 2015 LTIP authorizes the Board to grant stock options, stock appreciation rights, restricted shares, restricted share units, performance awards, and dividend equivalents.  All grants are made by issuing new shares and no more than 4.0 million shares of common stock may be issued under the 2015 LTIP.  As of December 31, 2024, we had 1.7 million shares remaining available for issuance under the 2015 LTIP.

Share-based compensation expense is included in selling, general, and administrative expense.  The income tax effect associated with share-based compensation awards is included in income tax expense.  

The following table presents share-based compensation amounts recognized in our Consolidated Statements of Operations, in thousands:

Year Ended December 31, 

2024

2023

2022

Share-based compensation expense

$

16,579

$

15,838

$

12,310

Income tax (expense)/benefit

$

(1,942)

$

1,356

$

1,733

The following table presents a summary of our share-based compensation activity for the year ended December 31, 2024, in thousands, except per share amounts:

RSAs

Stock Options

Number of Shares

   

Weighted Average Grant Date Fair Value Per Share

   

Number of Shares

   

Weighted Average Grant Date Fair Value Per Share

   

Weighted Average Exercise Price Per Share

   

Aggregate
Intrinsic
Value

Balance December 31, 2023

195.5

$

223.49

128.7

$

36.65

$

98.58

$

35,462.8

Granted

46.0

$

419.05

$

$

Converted/Exercised

(53.1)

$

229.38

(16.0)

$

82.64

$

201.27

$

3,312.8

Forfeited/Expired

(12.4)

$

283.09

$

$

Balance December 31, 2024

176.0

$

269.50

112.7

$

30.10

$

83.97

$

25,604.9

Exercisable December 31, 2024 (a)

112.7

$

30.10

$

83.97

$

25,604.9

(a) The weighted average remaining contractual term for vested stock options is 4.2 years.

We had unrecognized share-based compensation expense relating to unvested awards as shown in the following table, dollars in thousands:

As of December 31, 2024

Unrecognized Compensation Expense
on Unvested Awards

Weighted Average
Remaining
Compensation Expense Period

RSAs

$

18,634

0.9

Stock options

Total unrecognized compensation expense related to unvested awards

$

18,634

Our RSAs with performance-based conditions are evaluated on a quarterly basis with adjustments to compensation expense based on the likelihood of the performance target being achieved or exceeded.  The following table shows the range of payouts and the related expense for our outstanding RSAs with performance-based conditions, in thousands:

Payout Ranges and Related Expense

RSAs with Performance-Based Conditions

Grant Date Fair Value

0%

25%

100%

200%

February 15, 2022

$

2,907

$

-

$

727

$

2,907

$

5,814

February 21, 2023

$

3,830

$

-

$

958

$

3,830

$

7,660

February 21, 2024

$

4,452

$

-

$

1,113

$

4,452

$

8,904

During the first quarter of 2024, RSAs with performance-based conditions that were granted on February 16, 2021 vested based on cumulative three-year achievement of 200%. Total compensation expense recognized over the three-year performance period, net of forfeitures, was $4.4 million.

The fair value of our RSAs with a market-based condition granted under the 2015 LTIP was determined using a Monte Carlo simulation.  The following are key inputs in the Monte Carlo analysis for awards granted in 2024, 2023 and 2022:

2024

2023

2022

Measurement period (years)

2.86

2.86

2.87

Risk free interest rate

4.36

%

4.42

%

1.76

%

Dividend yield

0.00

%

0.00

%

0.00

%

Estimated fair value of market-based RSAs at grant date

$

503.68

$

270.64

$

298.20

As a result of the Company's performance against a group of peers based on relative total shareholder return, our RSAs with a market-based condition that were granted on February 15, 2022, did not meet the established performance criteria, and will be forfeited in the first quarter of 2025.